Logo Image
News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMEDcast SeriesMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsShortsSponsored WebcastStudent VoicesThe Weekly DoseWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsPartnersPulse PointSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • Allergy
    • Asthma
  • Biosimilars
  • Cardiovascular Health
    • Heart Failure
    • Cholesterol
  • Chronic Kidney Disease
  • Classical Hematology
    • Immunoglobulins
    • Neutropenia
  • Dermatology
    • Psoriasis
    • Atopic Dermatitis
  • Endocrinology
    • Continuous Glucose Monitoring
    • Diabetes
    • Osteoporosis
  • Eye Care
    • Macular Degeneration
    • Dry Eye Disease
  • Future of Pharmacy
  • Gastrointestinal Health
    • Digestive Health
  • Hematology
    • Multiple Myeloma
    • Lymphoma
    • Myelofibrosis
    • Chronic Lymphocytic Leukemia
  • Hepatitis/MASH
  • Infectious Disease
    • Respiratory Syncytial Virus
    • Pneumococcal
    • C. difficile
    • COVID-19
    • Flu
    • HIV
    • PrEP
    • COVID Treatment
  • Neurology
    • Multiple Sclerosis
    • Alzheimer Disease
    • Epilepsy
    • Migraine
    • Sleep
    • Shingles
    • Alzheimer Disease
    • Movement Disorders
    • Parkinson Disease
  • Oncology
    • Cholangiocarcinoma
    • Endometrial Cancer
    • Immuno-oncology
    • Lung Cancer
    • Prostate Cancer
    • Skin Cancer
    • Ovarian Cancer
    • Breast Cancer
    • Cervical Cancer
    • Gastrointestinal Cancer
    • Colorectal Cancer
    • HER2 Breast Cancer
  • Pain Management
  • Pediatrics
  • Psychiatry
    • Psychedelics
    • Schizophrenia
    • ADHD
    • Brain Health
    • Mental Health
    • Bipolar Disorder
    • Anxiety
    • Depression
  • Pulmonology
    • COPD
    • Cough and Cold
  • Rheumatology
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Vaccines
    • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
    • Reproductive Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Brianna Burke, PharmD Candidate

Advertisement

Articles by Brianna Burke, PharmD Candidate

A headache is pain or discomfort in the head or face area. Types of headaches include migraine, tension, and cluster. Headaches can be primary or secondary | Image Credit: Thipphaphone | stock.adobe.com

Psychedelics in Cluster Headaches Are Breaking the Pain Cycle

ByAlyviah Paquette, BS Pharm, 2026 PharmD Candidate,Sara L. Tolliday, PharmD, RPh,Jillian Hernandez, MS, BS, BA,Brianna Burke, PharmD Candidate
July 14th 2026

Emerging data on psychedelics demonstrate efficacy in preventing cluster headaches.

Advertisement

Latest Updated Articles

  • A headache is pain or discomfort in the head or face area. Types of headaches include migraine, tension, and cluster. Headaches can be primary or secondary | Image Credit: Thipphaphone | stock.adobe.com
    Psychedelics in Cluster Headaches Are Breaking the Pain Cycle

    July 14th 2026



Advertisement
Advertisement

Trending on Pharmacy Times

1

Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know

2

FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief

3

What Real-World Data Show About Moving Patients From Humira to Biosimilars

4

New Review Offers Framework for Sequencing Disease-Modifying Therapies in MS

5

Emavusertib-Based Therapy Produces Responses in BTK Inhibitor–Treated Primary CNS Lymphoma

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us